"chemotherapy response scores" trang 4 - tải miễn phí từ tailieunhanh
Percent change in apparent difusion coefcient and plasma EBV DNA after induction chemotherapy identifies distinct prognostic response phenotypes in advanced nasopharyngeal carcinoma

Percent change in apparent difusion coefcient and plasma EBV DNA after induction chemotherapy identifies distinct prognostic response phenotypes in advanced nasopharyngeal carcinoma
9    51    3
18FDG-PET-CT identifies histopathological non-responders after neoadjuvant chemotherapy in locally advanced gastric and cardia cancer: Cohort study

18FDG-PET-CT identifies histopathological non-responders after neoadjuvant chemotherapy in locally advanced gastric and cardia cancer: Cohort study
7    85    1
High OX40 expression in recurrent ovarian carcinoma is indicative for response to repeated chemotherapy

High OX40 expression in recurrent ovarian carcinoma is indicative for response to repeated chemotherapy
9    42    1
NUP98 – a novel predictor of response to anthracycline-based chemotherapy in triple negative breast cancer

NUP98 – a novel predictor of response to anthracycline-based chemotherapy in triple negative breast cancer
13    52    1
Association between CHEK2 H371Y mutation and response to neoadjuvant chemotherapy in women with breast cancer

Association between CHEK2 H371Y mutation and response to neoadjuvant chemotherapy in women with breast cancer
8    26    1
Correlation between ERK1 and STAT3 expression and chemoresistance in patients with conventional osteosarcoma

Correlation between ERK1 and STAT3 expression and chemoresistance in patients with conventional osteosarcoma
11    27    1
TIM3 expression on TILs is associated with poor response to neoadjuvant chemotherapy in patients with locally advanced triple-negative breast cancer

TIM3 expression on TILs is associated with poor response to neoadjuvant chemotherapy in patients with locally advanced triple-negative breast cancer
13    40    1
Pre-clinical and clinical studies on the role of RBM3 in muscle-invasive bladder cancer: Longitudinal expression, transcriptome-level effects and modulation of chemosensitivity

Pre-clinical and clinical studies on the role of RBM3 in muscle-invasive bladder cancer: Longitudinal expression, transcriptome-level effects and modulation of chemosensitivity
15    16    1
A multi‑centre randomized controlled trial investigating Consolidation Chemotherapy with and without oxaliplatin in distal rectal cancer and Watch & Wait

A multi‑centre randomized controlled trial investigating Consolidation Chemotherapy with and without oxaliplatin in distal rectal cancer and Watch & Wait
10    7    1
Multidisciplinary treatment for patients with stage IV gastric cancer: The role of conversion surgery following chemotherapy

Multidisciplinary treatment for patients with stage IV gastric cancer: The role of conversion surgery following chemotherapy
12    59    1
Agreement between MRI and pathologic breast tumor size after neoadjuvant chemotherapy, and comparison with alternative tests: Individual patient data meta-analysis

Agreement between MRI and pathologic breast tumor size after neoadjuvant chemotherapy, and comparison with alternative tests: Individual patient data meta-analysis
12    31    1
Ki67 expression and the effect of neo-adjuvant chemotherapy on luminal HER2-negative breast cancer

Ki67 expression and the effect of neo-adjuvant chemotherapy on luminal HER2-negative breast cancer
7    31    1
Digital phenotyping in young breast cancer patients treated with neoadjuvant chemotherapy (the NeoFit Trial): Protocol for a national, multicenter single-arm trial

Digital phenotyping in young breast cancer patients treated with neoadjuvant chemotherapy (the NeoFit Trial): Protocol for a national, multicenter single-arm trial
9    21    1
Analysis of neoadjuvant chemotherapy for breast cancer: A 20-year retrospective analysis of patients of a single institution

Analysis of neoadjuvant chemotherapy for breast cancer: A 20-year retrospective analysis of patients of a single institution
9    7    1
The validity of neoadjuvant chemotherapy with paclitaxel plus S-1 is not inferior to that of SOX regimen for locally advanced gastric cancer: An observational study

The validity of neoadjuvant chemotherapy with paclitaxel plus S-1 is not inferior to that of SOX regimen for locally advanced gastric cancer: An observational study
9    1    1
Mammographic density is a potential predictive marker of pathological response after neoadjuvant chemotherapy in breast cancer

Mammographic density is a potential predictive marker of pathological response after neoadjuvant chemotherapy in breast cancer
11    95    0
Potential of extravasated platelet aggregation as a surrogate marker for overall survival in patients with advanced gastric cancer treated with preoperative docetaxel, cisplatin and S-1: A retrospective observational study

Potential of extravasated platelet aggregation as a surrogate marker for overall survival in patients with advanced gastric cancer treated with preoperative docetaxel, cisplatin and S-1: A retrospective observational study
11    50    1
Organ Preservation in Rectal Adenocarcinoma: A phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management

Organ Preservation in Rectal Adenocarcinoma: A phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management
13    86    1
Chemotherapy, host response and molecular dynamics in periampullary cancer: The CHAMP study

Chemotherapy, host response and molecular dynamics in periampullary cancer: The CHAMP study
7    67    0
Báo cáo y học:

Báo cáo y học: " Response of pulmonary artery intimal sarcoma to surgery, radiotherapy and chemotherapy: a case report"
3    34    0